Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MedPulser Electroporation with Bleomycin for Cutaneous and Subcutaneous Tumors
2005-000402-32Phase 4Completed
- Sponsor
- Inovio Pharmaceuticals, Inc.
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bleomycin in cutaneous squamous cell carcinoma (cSCC), basal cell carcinoma (BCC), melanoma and 1 more, sponsored by Inovio Pharmaceuticals, Inc. Primary endpoint: Local tumor control. Started Mar 2005; status: completed.
02
Drugs
bleomycin
03
Conditions
cutaneous squamous cell carcinoma (cSCC)basal cell carcinoma (BCC)melanomaAdenocarcinoma
Beyond the preview
Go deeper on 2005-000402-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000402-32.